Orthomega Select EPA
Orthomega Select EPA is an Omega & Fish Oil supplement, specifically a fat/fatty acid product, focusing on essential fatty acids. Each 1-softgel serving provides 660 mg of Eicosapentaenoic Acid (EPA) and 60 mg of Docosahexaenoic Acid (DHA). The 660 mg of EPA is at a clinically studied dosage for various health benefits. However, the 60 mg of DHA is considered underdosed compared to amounts often recommended for comprehensive omega-3 support. The product achieves an N+ Score of 58, resulting in an 'F' grade, largely due to the significantly lower DHA content relative to EPA. With 5 total ingredients, the label is transparent regarding the specific fatty acid breakdown. This supplement may be suitable for individuals prioritizing a high dose of EPA, but those seeking a balanced or higher DHA intake may need to supplement further.
About This Product
Orthomega Select EPA by Ortho Molecular Products is a omega & fish oil supplement containing 5 active ingredients. It has earned an N+ Score of 58/100 (Grade F).
Notable clinical-dose ingredients include Eicosapentaenoic Acid.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +1 ingredient(s) at clinical dose levels
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (5 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Calories | 15.000 Calorie(s) | N/A |
| Total Fat | 1.500 Gram(s) | N/A |
| Eicosapentaenoic Acid | 660.000 mg | Optimal |
| Docosahexaenoic Acid | 60.000 mg | Under |
| Cholesterol | 5.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.